Thalidomide once more topical;Thalidomide opnieuw in de belangstelling

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 46, 1998, Pages 2509-2512

  De Jong Van Den Berg, L T W ^a,b   Rutgers, J ^a,b   Cornel, M C ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Gromnger Institute for Drug Studies

^c EUROCAT Registratie Van A ^*

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ARTICLE; AUTOIMMUNE DISEASE; DISEASE CONTROL; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; ERYTHEMA NODOSUM LEPROSUM; FOOD AND DRUG ADMINISTRATION; HUMAN; LIMB DEFECT; PATIENT MONITORING; TOPICAL DRUG ADMINISTRATION;

ADULT; BONE MARROW TRANSPLANTATION; DRUG AND NARCOTIC CONTROL; DRUG APPROVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; NETHERLANDS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STOMATITIS, APHTHOUS; TERATOGENS; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 0032517562     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The Sunday Times Insight Team. Suffer the children. (The story of thalidomide). London: Deutsch, 1979
2. Kelsey FO. Thalidomide update: regulatory aspects. Teratology 1988: 38:221-6.
3. Lenz W. A short history of thalidomide embryopathy. Teratology 1988;38:203-15.
4. Marwick C. Thalidomide back - under strict control. JAMA 1997; 276:1135-7.
5. Bach A, Bichel J, Hejgaard JJ. Studies on the possible anti-neoplastic effect of thalidomide. Acta Path Microbiol Scand 1963;58-59:491-9.
6. Olson KB, Hall TC, Horton J, Khung CL, Hosley HF. Thalidomide in the treatment of advanced cancer. Clinical Pharmacology and Therapeutics 1965;6:292-7.
7. Grabstald H, Golbey R. Clinical experiences with thalidomide in patients with cancer. Clinical Pharmacology and Therapeutics 1965; 6:298-302
8. Muckter H, Moré E. Thalidomid und Tumor. Arzneimittelforschung 1966;16:129-34.
9. Chaudhry AP, Schmutz jr JA. Effects of prednisolone and thalidomide on induced submandibular gland tumors in hamsters. Cancer Res 1966;26:1884-6
10. Hastings RC, Leprosy. In: Conn JW, editor. Current therapy. Philadelphia: Saunders. 1979:32-6.
11. Jakeman P, Smith WCS. Thalidomide in leprosy reaction. Lancet 1994;343:432-3.
12. Castilla EE, Ashton-Prolla P, Barreda-Mejia E, Brunoni D, Cavalcanti DP, Correa-Neto J, et at. Thalidomide, a current teratogen in South America. Teratology 1996;54:273-7.
13. Thompson C. Thalidomide effective for AIDS-related oral ulcers. Lancet 1995;346:1289.
14. Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group. N Engl J Med 1997;336:1487-93
15. Makonkawkeyoon S, Limson-Pobre RNR, Moreira AL, Schauf V, Kaplan G Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:5974-8.
16. Thalidomide in cancer trials. Scrip 1996;2120:21.
17. Further uses for thalidormide Scrip 1995;2054:22.
18. Minor JR, Piscitelh SC. Thalidomide in diseases associated with human immunodeficiency virus infection. Am J Health Syst Pharm 1996;53:429-31.
19. Bernal JE, Duran MM, Londono F, Umaha A. Cellular immune effects of thalidomide in actinic prurigo [letter]. Int J Dermatol 1992; 31:599-600.
20. Wood PMD, Pricter SJ. The potential use of thalidomide in the therapy of graft-versus-host disease - a review of clinical and laboratory information. Leukaemia Research 1990;14:395-9.
21. Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE, Jabs DA, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992;326:1055-8.
22. Parker PM, Chao N, Nademanee A, O'Donnell MR, Schmidt GM, Snyder DS, et al. Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood 1995;86:3604-9.
23. Hasper MF. Thalidomide en chronische cutane lupus erythematosus [abstract]. Ned Tijdschr Genecskd 1983;127:1028-9.
24. Gutierrez-Rodiguez O. Thalidomide. A promising new treatment for rheumatoid arthritis. Arthritis Rheum 1984;27:1118-21.
25. Sheehan NJ. Thalidomide neurotoxicity and rheumatoid arthritis. Arthritis Rheum 1986;29:1296.
26. Die-Smulders CEM de, Sturkenboom MCJM, Veraart J, Katwijk C van. Sastrowijoto P, Linden E van der. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. Teratology 1995;52:215-9.